{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:52:02Z","timestamp":1774273922036,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"DOI":"10.7759\/cureus.86424","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:53:47Z","timestamp":1750424027000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Colchicine in Reducing Cardiovascular Events in Patients with Acute Coronary Syndrome: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Mayuri","family":"Quishpe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Sanunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cunuhay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlyn","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Endara-Mina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134417","article-title":"Ideal cardiovascular health and risk of cardiovascular events or mortality: a systematic review and meta-analysis of prospective studies","volume":"12","author":"Radovanovic M","year":"2023","unstructured":"Radovanovic M, Jankovic J, Mandic-Rajcevic S, Dumic I, Hanna RD, Nordstrom CW. Ideal cardiovascular health and risk of cardiovascular events or mortality: a systematic review and meta-analysis of prospective studies. J Clin Med. 2023, 12:4417. 10.3390\/jcm12134417","journal-title":"J Clin Med"},{"key":"ref2","unstructured":"Cardiovascular diseases. (2025). Accessed. 2025: https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson K","year":"2023","unstructured":"Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week. J Am Coll Cardiol. 2023, 82:648-60. 10.1016\/j.jacc.2023.05.055","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00884-0","article-title":"Global epidemiology of acute coronary syndromes","volume":"20","author":"Timmis A","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023, 20:778-88. 10.1038\/s41569-023-00884-0","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31083\/RCM27942","article-title":"Platelet-to-lymphocyte ratio efficiency in predicting major adverse cardiovascular events after percutaneous coronary intervention in acute coronary syndromes: a meta-analysis","volume":"26","author":"Wang H","year":"2025","unstructured":"Wang H, Zulikaier T, Yumaierjiang B, Lyu S, He P. Platelet-to-lymphocyte ratio efficiency in predicting major adverse cardiovascular events after percutaneous coronary intervention in acute coronary syndromes: a meta-analysis. Rev Cardiovasc Med. 2025, 26:27942. 10.31083\/RCM27942","journal-title":"Rev Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2022.02.001","article-title":"A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis","volume":"33","author":"Melendo-Viu M","year":"2023","unstructured":"Melendo-Viu M, March\u00e1n-Lopez \u00c1, Guarch CJ, et al.. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis. Trends Cardiovasc Med. 2023, 33:319-26. 10.1016\/j.tcm.2022.02.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-024-10101-5","article-title":"New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation","volume":"19","author":"Kodi T","year":"2024","unstructured":"Kodi T, Sankhe R, Gopinathan A, Nandakumar K, Kishore A. New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J Neuroimmune Pharmacol. 2024, 19:7. 10.1007\/s11481-024-10101-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson S","year":"2016","unstructured":"Robertson S, Mart\u00ednez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond). 2016, 130:1237-46. 10.1042\/CS20160090","journal-title":"Clin Sci (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention","volume":"10","author":"Vaidya K","year":"2021","unstructured":"Vaidya K, Tucker B, Kurup R, et al.. Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention. J Am Heart Assoc. 2021, 10:e018993. 10.1161\/JAHA.120.018993","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti C","year":"2024","unstructured":"Bouleti C, Viscogliosi S, Bresson D, et al.. Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up. Open Heart. 2024, 11:e002474. 10.1136\/openhrt-2023-002474","journal-title":"Open Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaa045","article-title":"Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"7","author":"Samuel M","year":"2021","unstructured":"Samuel M, Tardif JC, Khairy P, et al.. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2021, 7:486-95. 10.1093\/ehjqcco\/qcaa045","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal TS","year":"2021","unstructured":"Opstal TS, Fiolet AT, van Broekhoven A, et al.. Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome. J Am Coll Cardiol. 2021, 78:859-66. 10.1016\/j.jacc.2021.06.037","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami M","year":"2021","unstructured":"Akrami M, Izadpanah P, Bazrafshan M, Hatamipour U, Nouraein N, Drissi HB, Manafi A. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial. BMC Cardiovasc Disord. 2021, 21:583. 10.1186\/s12872-021-02393-9","journal-title":"BMC Cardiovasc Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong DC","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, et al.. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020, 142:1890-900. 10.1161\/CIRCULATIONAHA.120.050771","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu M","year":"2024","unstructured":"Yu M, Yang Y, Dong SL, et al.. Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial. Circulation. 2024, 150:981-93. 10.1161\/CIRCULATIONAHA.124.069808","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07240-9","article-title":"Assessing the impact of colchicine on coronary plaque phenotype after myocardial infarction with optical coherence tomography: rationale and design of the COCOMO-ACS study","volume":"36","author":"Montarello NJ","year":"2022","unstructured":"Montarello NJ, Singh K, Sinhal A, et al.. Assessing the impact of colchicine on coronary plaque phenotype after myocardial infarction with optical coherence tomography: rationale and design of the COCOMO-ACS study. Cardiovasc Drugs Ther. 2022, 36:1175-86. 10.1007\/s10557-021-07240-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif JC","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, et al.. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019, 381:2497-505. 10.1056\/NEJMoa1912388","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly SS","year":"2025","unstructured":"Jolly SS, d'Entremont MA, Lee SF, et al.. Colchicine in acute myocardial infarction. N Engl J Med. 2025, 392:633-42. 10.1056\/NEJMoa2405922","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton N","year":"2021","unstructured":"Mewton N, Roubille F, Bresson D, et al.. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021, 144:859-69. 10.1161\/CIRCULATIONAHA.121.056177","journal-title":"Circulation"},{"key":"ref21","unstructured":"Acute coronary syndrome treatment & management. (2020). Accessed. 2025: https:\/\/emedicine.medscape.com\/article\/1910735-treatment?form=fpf."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos SG","year":"2022","unstructured":"Deftereos SG, Beerkens FJ, Shah B, et al.. Colchicine in cardiovascular disease: in-depth review. Circulation. 2022, 145:61-78. 10.1161\/CIRCULATIONAHA.121.056171","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe A","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res. 2018, 122:1722-40. 10.1161\/CIRCRESAHA.118.311362","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2020-0206","article-title":"Colchicine for cardiovascular medicine: a systematic review and meta-analysis","volume":"18","author":"Casula M","year":"2022","unstructured":"Casula M, Andreis A, Avondo S, Vaira MP, Imazio M. Colchicine for cardiovascular medicine: a systematic review and meta-analysis. Future Cardiol. 2022, 18:647-59. 10.2217\/fca-2020-0206","journal-title":"Future Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051240","article-title":"Colchicine for secondary cardiovascular prevention in coronary disease","volume":"142","author":"Roubille F","year":"2020","unstructured":"Roubille F, Tardif JC. Colchicine for secondary cardiovascular prevention in coronary disease. Circulation. 2020, 142:1901-4. 10.1161\/CIRCULATIONAHA.120.051240","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015003","article-title":"Colchicine for the primary prevention of cardiovascular events","volume":"2022","author":"Mart\u00ed-Carvajal AJ","year":"2022","unstructured":"Mart\u00ed-Carvajal AJ, De Sanctis JB, Hidalgo R, et al.. Colchicine for the primary prevention of cardiovascular events. Cochrane Database Syst Rev. 2022, 2022:CD015003. 10.1002\/14651858.CD015003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00314","article-title":"Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese Claims Database","volume":"43","author":"Imai S","year":"2020","unstructured":"Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y. Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese Claims Database. Biol Pharm Bull. 2020, 43:1519-25. 10.1248\/bpb.b20-00314","journal-title":"Biol Pharm Bull"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf SM","year":"2020","unstructured":"Nidorf SM, Fiolet AT, Mosterd A, et al.. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020, 383:1838-47. 10.1056\/NEJMoa2021372","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7775\/rac.es.v89.i1.19611","article-title":"Can colchicine prevent acute myocardial infarction? Systematic review and meta-analysis","volume":"89","author":"Masson W","year":"2021","unstructured":"Masson W, Lobo M, Lavalle-Cobo A, Molinero G. Can colchicine prevent acute myocardial infarction? Systematic review and meta-analysis. Rev Argent Cardiol. 2021, 89:42-9. 10.7775\/rac.es.v89.i1.19611","journal-title":"Rev Argent Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1175174","article-title":"Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis","volume":"10","author":"Liu Y","year":"2023","unstructured":"Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z. Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Front Cardiovasc Med. 2023, 10:1175174. 10.3389\/fcvm.2023.1175174","journal-title":"Front Cardiovasc Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073218","article-title":"Cardiovascular biomarkers: tools for precision diagnosis and prognosis","volume":"26","author":"Netala VR","year":"2025","unstructured":"Netala VR, Hou T, Wang Y, Zhang Z, Teertam SK. Cardiovascular biomarkers: tools for precision diagnosis and prognosis. Int J Mol Sci. 2025, 26:3218. 10.3390\/ijms26073218","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000001220","article-title":"Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes","volume":"34","author":"Alam M","year":"2023","unstructured":"Alam M, Kontopantelis E, Mamas MA, Savinova OV, Jhaveri A, Siddiqui E, Jhamnani S. Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes. Coron Artery Dis. 2023, 34:210-5. 10.1097\/MCA.0000000000001220","journal-title":"Coron Artery Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8317011","article-title":"Effect of treatment with colchicine after acute coronary syndrome on major cardiovascular events: a systematic review and meta-analysis of clinical trials","volume":"2022","author":"Razavi E","year":"2022","unstructured":"Razavi E, Ramezani A, Kazemi A, Attar A. Effect of treatment with colchicine after acute coronary syndrome on major cardiovascular events: a systematic review and meta-analysis of clinical trials. Cardiovasc Ther. 2022, 2022:8317011. 10.1155\/2022\/8317011","journal-title":"Cardiovasc Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02254-9","article-title":"A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease","volume":"112","author":"Chen T","year":"2023","unstructured":"Chen T, Liu G, Yu B. A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease. Clin Res Cardiol. 2023, 112:1487-505. 10.1007\/s00392-023-02254-9","journal-title":"Clin Res Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial","volume":"404","author":"Kelly P","year":"2024","unstructured":"Kelly P, Lemmens R, Weimar C, et al.. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. Lancet. 2024, 404:125-33. 10.1016\/S0140-6736(24)00968-1","journal-title":"Lancet"},{"key":"ref37","unstructured":"New favorable evidence for the use of colchicine in the treatment of DCVA. (2024). Accessed. 2025: https:\/\/portugues.medscape.com\/verartigo\/6511076?form=fpf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362984-efficacy-of-colchicine-in-reducing-cardiovascular-events-in-patients-with-acute-coronary-syndrome-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:53:48Z","timestamp":1750424028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362984-efficacy-of-colchicine-in-reducing-cardiovascular-events-in-patients-with-acute-coronary-syndrome-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.86424","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}